RXST — RxSight, Inc.
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1111485 ·
Last close
$4.67
Market Cap
$194.24M
52W High
$13.22
52W Low
$4.48
ADV30
830,838
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 33,741,000 | 25,886,000 | -13,770,000 | -12,097,000 | 352,700,000 | 13,352,000 | 89,360,000 |
| Mar 2026 | 30,893,000 | 23,498,000 | -17,829,000 | -15,884,000 | 303,993,000 | 17,573,000 | 36,698,000 |
| Dec 2025 | 32,608,000 | 25,263,000 | -11,337,000 | -9,152,000 | 311,814,000 | 19,949,000 | 36,131,000 |
| Sep 2025 | 30,340,000 | 24,227,000 | -12,178,000 | -9,816,000 | 308,533,000 | 29,633,000 | 32,563,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-22,732,000
Investing CF
$-5,118,000
Financing CF
$859,000
CapEx
$-4,433,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.13
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-689,020,000
Inventory
$37,117,000
Receivables
$78,519,000
ST Investments
$195,447,000
EBIT TTM
$-46,825,000
Pretax Income TTM
$-46,840,000
Interest Exp TTM
$15,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$127,582,000
EBITDA
$-51,575,000
Free Cash Flow
$-6,730,375
Enterprise Value
$52,172,400
Total Cash
$208,799,008
Total Debt
$10,580,000
Shares Out
41,593,256
Trailing EPS
$-1.14
Book Value
$6.33
ROE
-17.3%
ROA
-10.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 134,479,000 | -48,191,000 | -38,944,000 | 311,814,000 | 36,131,000 | 275,683,000 | -15,511,000 |
| Dec 2024 | 139,927,000 | -36,858,000 | -27,455,000 | 318,563,000 | 37,325,000 | 281,238,000 | -16,946,000 |
| Dec 2023 | 89,077,000 | -50,085,000 | -48,608,000 | 182,550,000 | 22,188,000 | 160,362,000 | -41,593,000 |
| Dec 2022 | 49,005,000 | -63,318,000 | -66,756,000 | 150,164,000 | 60,262,000 | 89,902,000 | -58,850,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.70
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $4.67 · call volume: 15 · put volume: 101
Expected Move to 2026-12-18:
±$1.04
(22.27%) —
implied range
$3.63 –
$5.71
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TPVG | TriplePoint Venture Growth BDC Corp. | $194.59M | $4.78 | — |
| GGT | GABELLI MULTIMEDIA TRUST INC. | $196.76M | $3.98 | — |
| FC | FRANKLIN COVEY CO | $191.43M | $16.95 | — |
| BANX | ArrowMark Financial Corp. | $191.20M | $19.74 | — |
| CMT | CORE MOLDING TECHNOLOGIES INC | $199.10M | $22.50 | — |
News headlines (Yahoo Finance, 1h cache)
RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says
2026-09-23 14:42 · Yahoo
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
2026-08-26 20:15 · Yahoo
RxSight (RXST) Q2 2026 Earnings Call Transcript
2026-08-12 23:01 · Yahoo
RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ...
2026-08-06 05:10 · Yahoo
RxSight Q2 Earnings Call Highlights
2026-08-06 05:03 · Yahoo
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
2026-08-05 20:05 · Yahoo
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline
2026-07-29 14:00 · Yahoo
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
2026-07-26 20:00 · Yahoo
RxSight (RXST) Stock Fair Value Falls After Soft Q2 Trends And Guidance Cut
2026-07-25 20:06 · Yahoo
RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?
2026-07-17 07:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.